Share Facebook Twitter LinkedIn Pinterest Email Shuttle Pharmaceuticals appoints Christopher Cooper as interim co-CEO
Chime Financial initiated with Buy at Loop Capital, price target set at $45 (CHYM:NASDAQ)September 9, 2026